PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsNHS may struggle to cope with personalised medicine

BioNews

NHS may struggle to cope with personalised medicine

Published 19 November 2012 posted in News and appears in BioNews 619

Author

Dr Kimberley Bryon-Dodd

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

The NHS is 'unprepared' to deal with personalised medicine in the clinic, according to Sir John Bell - the UK Government's chief genetics advisor - during an interview with the Times. His comments come as a four-year-old girl last week became Britain's first person to have a rare genetic disease identified through DNA sequencing...

The NHS is 'unprepared' to deal with personalised medicine in the clinic, according to Sir John Bell - the UK Government's chief genetics advisor - during an interview with the Times. His comments come as a four-year-old girl last week became Britain's first person to have a rare genetic disease identified through DNA sequencing.

Sir John told the Times: 'There has already been a lot of innovation, almost none of which has been adopted by the NHS. There's now lots of evidence that the benefits we'll get from this will be at least very large, and could be enormous'.

He added: 'There's more than enough we could be doing here, but the NHS is completely unprepared. This is not the future any more: it is a technology of today'. Personalised medicine can identify rare undiagnosed diseases, determine which drugs will be most effective in treating cancer and track bacterial infections such as MRSA (Methicillin [Multidrug]-Resistant Staphylococcus Aureus), the Times reports.

According to this report, geneticists attended a two-hour seminar organised by the UK's Prime Minister David Cameron last month to offer advice on how the NHS can make genetic medicine routine.

Sir John said that the NHS lacked the infrastructure to store large amounts of sensitive genetic information safely. There are concerns this could lead to privacy breaches or insurers demanding access to people's results and pushing up insurance premiums.

In his interview Sir John also said that upfront investment in genetic technology could save the NHS money by reducing the need for clinical tests and stopping patients being given ineffective drugs.

Dame Sally Davies, the UK's Chief Medical Officer, told the Times that the Government's NHS reforms would address some of Sir John's concerns. Research hospitals are also starting to use new genetic technology, she said.

Related Articles

PET BioNews
Reviews
5 February 2013 • 3 minutes read

Radio Review: Frontiers - Cancer Treatment

by Dr Sandy Raeburn

About 15 years ago, I formed the view we should be less ambitious about improving 'Public Understanding of Science' because we should not expect the public to understand genetic principles in detail. Better, I thought, to give a grounding in core science skills...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
Comment
10 January 2013 • 3 minutes read

You can change some of the NHS all the time, but you can't change all of the NHS all the time

by Chris Phillips

In Spring 2011 I was delighted to accept an invitation to join a panel of speakers at the Genetic Alliance UK conference in London. The session's main topic was the panel's view of the commissioning debate in the NHS....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
10 January 2013 • 2 minutes read

Successful trial of genetic test to guide personalised cancer therapy

by Dr Louisa Petchey

A new genetic test that will help to tailor drugs to cancer patients' individual tumours has been successfully trialled in the US...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 January 2013 • 2 minutes read

Think tank tells NHS: prepare for the genetic revolution

by Dr Rebecca Robey

The NHS must take steps to prepare for a revolution in genetics-based medicine, according to a new report by the independent think tank, the Foundation for Genomics and Public Health (the PHG Foundation). The Foundation says that rapid advances in technology will soon make it possible for individuals to have their entire genome analysed affordably, and this will have a major impact on many aspects of healthcare...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
22 November 2012 • 1 minute read

Genetic screening by nurses reduces specialist referrals

by Zara Mahmoud

Using nurses to pre-screen people for genetic risk of cancer, cardiac or endocrine disease before they're sent to specialist services can reduce referrals by up to 75 percent, a preliminary trial has found....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
19 November 2012 • 2 minutes read

Health disparities in the age of personalised medicine?

by Connie St Louis

The intersection of racial categories and emerging genetic technology is bound to be vexed given - for example - the long history of eugenics and segregation in the United States. Although the topic has received little attention among the UK general public, pharmaceutical companies on both sides of the Atlantic are investing huge amounts of research and development into individually tailored drugs - pharmacogenetics....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 November 2012 • 2 minutes read

Has personalised medicine arrived? Genome scan used to identify rare condition

by Ruth Pidsley

US scientists have reported possibly the first example of using one person's genetic sequence to refine a diagnosis and provide personalised medical treatment. Whole-genome sequencing (WGS) helped pinpoint defects in the DNA of 14-year-old fraternal twins Noah and Alexis Beery causing their rare neurological condition, dopamine-responsive dystonia (DRD)...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
2 November 2012 • 4 minutes read

Personalised medicine: a reality check

by Professor Donna Dickenson

The soaring promises made by personalised medicine advocates are probably loftier than in any other medical or scientific realm today. Francis Collins, former co-director of the Human Genome Project, wrote: 'We are on the leading edge of a true revolution in medicine, one that promises to transform the traditional "one size fits all" approach into a much more powerful strategy'...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 October 2010 • 1 minute read

Nuffield launches 'personalised healthcare' report

by MacKenna Roberts

The UK's Nuffield Council on Bioethics has reported that direct-to-consumer personal genetic profiling services used to predict people's genetic susceptibility for common diseases, such as Parkinson's and diabetes, are often inconclusive, misleading and can potentially cause unnecessary anxiety, complacency or distress when no treatment is available...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
4 June 2010 • 2 minutes read

Personalised cancer therapy on the NHS

by Dr Lux Fatimathas

Cancer patients in the UK are to be treated with drugs specific to the genetic make-up of their individual tumours. A new initiative, to be launched by the NHS this autumn, will test the tumours of up to 6000 cancer patients a year for known genetic mutations....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Genetic differences will help distinguish stomach cancers

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856